Key differences in RNA editing found between postmortem and living brain

FHS
July 3, 2024
10:41 am

Researchers examined the adenosine-to-inosine (A-to-I) nucleoside editing of postmortem and live prefrontal cortical tissues.

Congress must act now to protect the future of diagnostic tests

The 2024 election results will have vast consequences for health policy, but one of the less visible effects will be to once again disrupt how

November 15, 2024

Updated: Lilly details mid-stage win for tirzepatide in MASH with fibrosis data

Eli Lilly has unveiled fibrosis results from a Phase 2 test of tirzepatide in patients with metabolic dysfunction-associated steatohepatitis, or MASH, which could help further

June 6, 2024

Sickle cell cures are coming. African children can’t be left behind

The treatment of sickle cell disease is on the cusp of a historic breakthrough, with makers of two gene-based treatments for the debilitating blood disorder

July 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.